Additional file 1: of Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis

Yen-Hou Chang (Contributor)
Wai-Hou Li (Contributor)
Yi Chang (Contributor)
Chia-Wen Peng (Contributor)
Ching-Hsuan Cheng (Contributor)
Wei Pin Chang (Contributor)
Chi Mu Chuang (Contributor)

Dataset

1 Article

1 results

Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y-H., Li, W-H., Chang, Y., Peng, C-W., Cheng, C-H., Chang, W. P. & Chuang, C-M., 2016, In: BMC Cancer. 16, 1, p. 1-8 8 p.
Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus)